Literature DB >> 22544526

Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.

Julie C Baker-Lepain1, John A Lynch, Neeta Parimi, Charles E McCulloch, Michael C Nevitt, Maripat Corr, Nancy E Lane.   

Abstract

OBJECTIVE: To test whether single-nucleotide polymorphisms (SNPs) of the FRZB gene are associated with hip shape, and to determine whether FRZB variant alleles affect the relationship between hip shape and radiographic osteoarthritis (OA) of the hip.
METHODS: A nested case-control study of Caucasian women, age ≥65 years, from the Study of Osteoporotic Fractures cohort was performed. Cases (n = 451) were defined as subjects with radiographic evidence of incident hip OA during followup, while controls (n = 601) were subjects in whom no radiographic hip OA was identified at baseline or followup. Statistical shape modeling (SSM) of the digitized hip radiographs was performed to assess the shape of the proximal femur, using 10 independent modes of shape variation generated by principal components analysis. In addition, center-edge angle and acetabular depth were assessed as geometric measurements of acetabular shape. The association of the rs288326 and rs7775 FRZB variant alleles with hip shape was analyzed using linear regression. The effect of these alleles on the relationship between hip shape and radiographic hip OA was analyzed using a logistic regression model with or without inclusion of interaction terms.
RESULTS: The rs288326 and rs7775 alleles were associated with the shape of the proximal femur (SSM mode 2). There was a significant interaction between the rs288326 SNP and proximal femur shape (SSM mode 2) in predicting radiographic hip OA (P for interaction = 0.022). Among subjects with the rs288326 variant allele, there was an increased likelihood of radiographic hip OA in association with increasing quartiles of proximal femur shape mode 2 (for the fourth quartile of mode 2, odds ratio 2.5, 95% confidence interval 1.15, 5.25; P for linear trend = 0.02).
CONCLUSION: The rs288326 and rs7775 FRZB SNPs are associated with the shape of the proximal femur. The presence of the rs288326 SNP alters the relationship between proximal femur shape and incident radiographic hip OA. These findings suggest that FRZB may serve an important role in determining hip shape and may modify the relationship between hip shape and OA.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544526      PMCID: PMC3340442          DOI: 10.1002/art.34526

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  48 in total

1.  The genetic contribution to radiographic hip osteoarthritis in women: results of a classic twin study.

Authors:  A J MacGregor; L Antoniades; M Matson; T Andrew; T D Spector
Journal:  Arthritis Rheum       Date:  2000-11

2.  Introduction and WHO perspective on the global burden of musculoskeletal conditions.

Authors:  J Y Reginster; N G Khaltaev
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

Review 3.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

4.  Expression of Frzb-1 during chick development.

Authors:  D Duprez; L Leyns; M A Bonnin; F Lapointe; H Etchevers; E M De Robertis; N Le Douarin
Journal:  Mech Dev       Date:  1999-12       Impact factor: 1.882

5.  Mild acetabular dysplasia and risk of osteoarthritis of the hip: a case-control study.

Authors:  Daniel F McWilliams; Sally A Doherty; Wendy D Jenkins; Rose A Maciewicz; Kenneth R Muir; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2010-05-14       Impact factor: 19.103

6.  Type I collagen alpha1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women.

Authors:  K Lian; J M Zmuda; M C Nevitt; L Lui; M C Hochberg; D Greene; J Li; J Wang; N E Lane
Journal:  Arthritis Rheum       Date:  2005-05

7.  An assessment tool for predicting fracture risk in postmenopausal women.

Authors:  D M Black; M Steinbuch; L Palermo; P Dargent-Molina; R Lindsay; M S Hoseyni; O Johnell
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

Review 8.  The prevalence and burden of arthritis.

Authors:  J Y Reginster
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

9.  Comparative analysis of the expression and regulation of Wnt5a, Fz4, and Frzb1 during digit formation and in micromass cultures.

Authors:  J Chimal-Monroy; J A Montero; Y Gañan; D Macias; J A Garcia-Porrero; J M Hurle
Journal:  Dev Dyn       Date:  2002-07       Impact factor: 3.780

10.  Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium.

Authors:  H J M Kerkhof; I Meulenbelt; T Akune; N K Arden; A Aromaa; S M A Bierma-Zeinstra; A Carr; C Cooper; J Dai; M Doherty; S A Doherty; D Felson; A Gonzalez; A Gordon; A Harilainen; D J Hart; V B Hauksson; M Heliovaara; A Hofman; S Ikegawa; T Ingvarsson; Q Jiang; H Jonsson; I Jonsdottir; H Kawaguchi; M Kloppenburg; U M Kujala; N E Lane; P Leino-Arjas; L S Lohmander; F P Luyten; K N Malizos; M Nakajima; M C Nevitt; H A P Pols; F Rivadeneira; D Shi; E Slagboom; T D Spector; K Stefansson; A Sudo; A Tamm; A E Tamm; A Tsezou; A Uchida; A G Uitterlinden; J M Wilkinson; N Yoshimura; A M Valdes; J B J van Meurs
Journal:  Osteoarthritis Cartilage       Date:  2010-11-06       Impact factor: 6.576

View more
  34 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear?

Authors:  Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

Review 3.  Osteoarthritis and bone mineral density: are strong bones bad for joints?

Authors:  Sarah A Hardcastle; Paul Dieppe; Celia L Gregson; George Davey Smith; Jon H Tobias
Journal:  Bonekey Rep       Date:  2015-01-21

Review 4.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

5.  Learning osteoarthritis imaging biomarkers from bone surface spherical encoding.

Authors:  Alejandro Morales Martinez; Francesco Caliva; Io Flament; Felix Liu; Jinhee Lee; Peng Cao; Rutwik Shah; Sharmila Majumdar; Valentina Pedoia
Journal:  Magn Reson Med       Date:  2020-04-03       Impact factor: 4.668

Review 6.  To Wnt or not to Wnt: the bone and joint health dilemma.

Authors:  Rik J Lories; Maripat Corr; Nancy E Lane
Journal:  Nat Rev Rheumatol       Date:  2013-03-05       Impact factor: 20.543

Review 7.  Genetic epidemiology of osteoarthritis: recent developments and future directions.

Authors:  Marc C Hochberg; Laura Yerges-Armstrong; Michelle Yau; Braxton D Mitchell
Journal:  Curr Opin Rheumatol       Date:  2013-03       Impact factor: 5.006

8.  INHIBITION OF WINGLESS-RELATED INTEGRATION SITE (WNT) SIGNALLING MAY TREAT OSTEOARTHRITIS OF THE KNEE.

Authors:  Nancy E Lane
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

Review 9.  Hip ontogenesis: how evolution, genes, and load history shape hip morphotype and cartilotype.

Authors:  Tom Hogervorst; Wouter Eilander; Joost T Fikkers; Ingrid Meulenbelt
Journal:  Clin Orthop Relat Res       Date:  2012-12       Impact factor: 4.176

10.  Three-dimensional MRI-based statistical shape model and application to a cohort of knees with acute ACL injury.

Authors:  V Pedoia; D A Lansdown; M Zaid; C E McCulloch; R Souza; C B Ma; X Li
Journal:  Osteoarthritis Cartilage       Date:  2015-06-05       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.